• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同抗CD3双特异性抗体富集电荷变体的比较揭示了每个双特异性臂对翻译后修饰的不同敏感性。

Comparison of enriched charge variants from different anti-CD3 bispecific antibodies reveals differential susceptibility of each bispecific arm to post-translational modification.

作者信息

Nguyen Jennifer B, Liu Sophia, Howie Dylan A, Oberholtzer Zachary R, Ong Eric T, Rao Ramya, Prinston Jethro E, Dikiy Igor, Wu Jikang, Wu Zhijie, Zhao Yimeng, Li Meinuo, Molden Rosalynn, Molina Guido, Provoncha Kathleen, Sandu Cristinel, Qiu Haibo, Li Ning, Matousek William, Rosconi Michael P, Pyles Erica A

机构信息

Protein Biochemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.

Analytical Chemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.

出版信息

Protein Sci. 2025 Apr;34(4):e70079. doi: 10.1002/pro.70079.

DOI:10.1002/pro.70079
PMID:40116211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11926628/
Abstract

Charge heterogeneity is an important quality attribute of therapeutic antibodies, and a detailed understanding of charge heterogeneity arising from post-translational modifications (PTMs) is required by regulatory agencies during drug development. Among antibody therapeutics, the bispecific antibody with two distinct Fab domains targeting distinct antigens provides additional complexity to the charge profile. In this study, charge variant species were enriched from three bispecific antibodies (bsAbs) each containing one anti-CD3 binding arm designed with differential affinity to CD3. The charge heterogeneity corresponding to each anti-CD3 arm within each enriched fraction was evaluated using a domain-specific, digestion-assisted imaged capillary isoelectric focusing (icIEF) method known as DiCE. Through fractionation, we observed that the anti-CD3 arm of each bispecific antibody exhibited different distributions of acidic variants, even when the anti-CD3 arms were identical based on primary sequence. Reduced peptide mapping was performed on specific fractions to identify unique site-specific PTMs that were uncovered or enriched through fractionation. In each case, the bispecific arm that was most susceptible to PTMs exhibited a more basic isoelectric point. Conformational stability analysis of each bispecific antibody using differential scanning calorimetry suggested that the more basic Fab arm tended to be correlated with a lower melting temperature, although it is unclear the extent to which PTMs on the basic arm may contribute to reduced conformational stability. Overall, these results provide additional evidence that each of the two arms of a bispecific antibody may exhibit differential susceptibility to post-translational modification and that this susceptibility is likely correlated with subtle differences in overall bispecific antibody structure, which is influenced by electrostatic properties inherent to the primary sequence. Future studies to obtain high-resolution structures of full-length bispecific antibodies by crystallography or cryo-electron microscopy may help to elucidate the driving force for susceptibility to PTMs in bispecific antibodies.

摘要

电荷异质性是治疗性抗体的一个重要质量属性,在药物开发过程中,监管机构要求详细了解由翻译后修饰(PTM)产生的电荷异质性。在抗体治疗药物中,具有两个靶向不同抗原的不同Fab结构域的双特异性抗体使电荷分布情况更加复杂。在本研究中,从三种双特异性抗体(bsAb)中富集了电荷变体,每种双特异性抗体均含有一个针对CD3设计的具有不同亲和力的抗CD3结合臂。使用一种称为DiCE的结构域特异性、酶解辅助成像毛细管等电聚焦(icIEF)方法,对每个富集级分中与每个抗CD3臂相对应的电荷异质性进行了评估。通过分级分离,我们观察到,即使基于一级序列抗CD3臂相同,每种双特异性抗体的抗CD3臂也表现出不同的酸性变体分布。对特定级分进行了还原肽图谱分析,以鉴定通过分级分离发现或富集的独特的位点特异性PTM。在每种情况下,最易发生PTM的双特异性臂表现出更高的等电点。使用差示扫描量热法对每种双特异性抗体进行的构象稳定性分析表明,碱性更强的Fab臂往往与更低的解链温度相关,尽管尚不清楚碱性臂上的PTM在多大程度上可能导致构象稳定性降低。总体而言,这些结果提供了额外的证据,表明双特异性抗体的两条臂中的每一条可能对翻译后修饰表现出不同的敏感性,并且这种敏感性可能与双特异性抗体整体结构中的细微差异相关,而这种差异受一级序列固有的静电性质影响。未来通过晶体学或冷冻电子显微镜获得全长双特异性抗体高分辨率结构的研究,可能有助于阐明双特异性抗体对PTM敏感性的驱动力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/11926628/06b471c25006/PRO-34-e70079-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/11926628/bea2b3c24f61/PRO-34-e70079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/11926628/36bbe511a550/PRO-34-e70079-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/11926628/06b471c25006/PRO-34-e70079-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/11926628/bea2b3c24f61/PRO-34-e70079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/11926628/36bbe511a550/PRO-34-e70079-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9354/11926628/06b471c25006/PRO-34-e70079-g002.jpg

相似文献

1
Comparison of enriched charge variants from different anti-CD3 bispecific antibodies reveals differential susceptibility of each bispecific arm to post-translational modification.不同抗CD3双特异性抗体富集电荷变体的比较揭示了每个双特异性臂对翻译后修饰的不同敏感性。
Protein Sci. 2025 Apr;34(4):e70079. doi: 10.1002/pro.70079.
2
Development of a platform method for rapid detection and characterization of domain-specific post-translational modifications in bispecific antibodies.开发一种平台方法,用于快速检测和表征双特异性抗体中特定结构域的翻译后修饰。
J Pharm Biomed Anal. 2024 Jul 15;244:116120. doi: 10.1016/j.jpba.2024.116120. Epub 2024 Mar 18.
3
Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms.基于抗CD3的双特异性抗体设计用于治疗人类B细胞恶性肿瘤,可通过抗原依赖性和抗原非依赖性机制诱导T细胞活化。
Int J Cancer. 1998 Jul 17;77(2):251-6. doi: 10.1002/(sici)1097-0215(19980717)77:2<251::aid-ijc14>3.0.co;2-e.
4
Rapid multi-attribute characterization of intact bispecific antibodies by a microfluidic chip-based integrated icIEF-MS technology.基于微流控芯片集成等电聚焦-质谱联用技术的完整双特异性抗体的快速多属性表征。
Electrophoresis. 2023 Feb;44(3-4):378-386. doi: 10.1002/elps.202200165. Epub 2022 Oct 25.
5
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties.单细胞产生和体外组装的抗 FcRH5/CD3 T 细胞依赖性双特异性抗体具有相似的体外和体内特性。
MAbs. 2019 Feb/Mar;11(2):422-433. doi: 10.1080/19420862.2018.1551676. Epub 2018 Dec 17.
6
Influence of the bispecific antibody IgG subclass on T cell redirection.双特异性抗体 IgG 亚类对 T 细胞重定向的影响。
MAbs. 2019 Aug/Sep;11(6):1012-1024. doi: 10.1080/19420862.2019.1624464. Epub 2019 Jun 26.
7
CD3 Target Affinity Chromatography Mass Spectrometry as a New Tool for Function-Structure Characterization of T-Cell Engaging Bispecific Antibody Proteoforms and Product-Related Variants.CD3靶向亲和色谱质谱法作为一种用于T细胞接合双特异性抗体蛋白异构体和产品相关变体功能结构表征的新工具。
Anal Chem. 2023 Jan 31;95(4):2260-2268. doi: 10.1021/acs.analchem.2c03827. Epub 2023 Jan 13.
8
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies.新型 T 细胞激动型双特异性抗体实现高效肿瘤杀伤和最小细胞因子释放。
MAbs. 2019 May/Jun;11(4):639-652. doi: 10.1080/19420862.2019.1574521. Epub 2019 Feb 20.
9
Fab-based bispecific antibody formats with robust biophysical properties and biological activity.具有强大生物物理特性和生物活性的基于Fab的双特异性抗体形式。
MAbs. 2015;7(3):470-82. doi: 10.1080/19420862.2015.1022694.
10
Characterization of charge variants, including post-translational modifications and proteoforms, of bispecific antigen-binding protein by cation-exchange chromatography coupled to native mass spectrometry.采用阳离子交换色谱法结合天然质谱法对双特异性抗原结合蛋白的电荷变异体(包括翻译后修饰和蛋白构象)进行表征。
Talanta. 2024 Jan 1;266(Pt 1):125062. doi: 10.1016/j.talanta.2023.125062. Epub 2023 Aug 8.

本文引用的文献

1
Cancer therapy with antibodies.抗体癌症疗法。
Nat Rev Cancer. 2024 Jun;24(6):399-426. doi: 10.1038/s41568-024-00690-x. Epub 2024 May 13.
2
Development of a platform method for rapid detection and characterization of domain-specific post-translational modifications in bispecific antibodies.开发一种平台方法,用于快速检测和表征双特异性抗体中特定结构域的翻译后修饰。
J Pharm Biomed Anal. 2024 Jul 15;244:116120. doi: 10.1016/j.jpba.2024.116120. Epub 2024 Mar 18.
3
A pivotal decade for bispecific antibodies?双特异性抗体的关键十年?
MAbs. 2024 Jan-Dec;16(1):2321635. doi: 10.1080/19420862.2024.2321635. Epub 2024 Mar 11.
4
The present and future of bispecific antibodies for cancer therapy.双特异性抗体在癌症治疗中的现在和未来。
Nat Rev Drug Discov. 2024 Apr;23(4):301-319. doi: 10.1038/s41573-024-00896-6. Epub 2024 Mar 6.
5
Biparatopic antibodies: therapeutic applications and prospects.双靶向抗体:治疗应用与前景。
MAbs. 2024 Jan-Dec;16(1):2310890. doi: 10.1080/19420862.2024.2310890. Epub 2024 Mar 4.
6
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors.T 细胞刺激疫苗增强了 CD3 双特异性抗体疗法在实体肿瘤中的疗效。
Nat Commun. 2024 Jan 2;15(1):48. doi: 10.1038/s41467-023-44308-6.
7
Predicting evolutionary outcomes through the probability of accessing sequence variants.通过获取序列变异的概率来预测进化结果。
Sci Adv. 2023 Jul 28;9(30):eade2903. doi: 10.1126/sciadv.ade2903.
8
Modulating T Cell Responses by Targeting CD3.通过靶向CD3调节T细胞反应
Cancers (Basel). 2023 Feb 13;15(4):1189. doi: 10.3390/cancers15041189.
9
Current landscape and future directions of bispecific antibodies in cancer immunotherapy.双特异性抗体在癌症免疫治疗中的现状和未来方向。
Front Immunol. 2022 Oct 28;13:1035276. doi: 10.3389/fimmu.2022.1035276. eCollection 2022.
10
Low pK of Lys promotes glycation at one complementarity-determining region of a bispecific antibody.赖氨酸低 pK 值可促进双特异性抗体一个互补决定区的糖基化。
Biophys J. 2022 Mar 15;121(6):1081-1093. doi: 10.1016/j.bpj.2022.02.002. Epub 2022 Feb 2.